Medicine
ATROPEN Auto-Injector 2 mg/0.7 mL injection
ATROPEN Auto-Injector 2 mg/0.7 mL injection is a prescription medicine containing Atropine for intramuscular use, marketed by Meridian Medical Technologies, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Keep from freezing. Store between 20ºC to 25ºC (68ºF to 77ºF), excursions…
Key facts
- Active ingredient (INN)
- Atropine
- Brand
- ATROPEN Auto-Injector
- Strength
- 2 mg/0.7 mL
- Dosage form
- Injection
- Route
- Intramuscular
- Packs
- .7 mL
- Marketing authorisation holder
- Meridian Medical Technologies
- Manufacturer
- Meridian Medical Technologies
- Origin register
- US FDA, United States
- Storage
- Keep from freezing. Store between 20ºC to 25ºC (68ºF to 77ºF), excursions permitted between 15ºC and 30ºC (between 59ºF and 86ºF). Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A03BA01 Atropine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 15 May 1973
- Identifiers
- RxCUI 1190536, 1190538, 1190540 +5DailyMed set ID e2d4307d-da8f-49f5-aac0-02355dd9ffb7NDC 11704-106, 11704-101Application NDA017106
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| .7 mL in 1 syringe, plastic | 11704-101-01 | Meridian Medical Technologies | 15 May 1973 |
| .7 mL in 1 syringe, plastic | 11704-106-01 | Meridian Medical Technologies | 19 June 2003 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Atropine 2 mg/0.7 mL injection.
Other strengths and forms of Atropine
Clinical summary
Atropine is an anticholinergic indicated for the treatment of poisoning by susceptible organophosphorus nerve agents having cholinesterase activity as well as organophosphorus or carbamate insecticides in adult and pediatric patients. MedsAcross supplies Atropine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AtropineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- ATROPEN Auto-Injector prescribing information (Meridian Medical Technologies) · U.S. National Library of Medicine, DailyMed
- Ryjunea: European public assessment report (EPAR) · European Medicines Agency
Need ATROPEN Auto-Injector 2 mg/0.7 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.